It may help to remember that the needles used for GLP-1 medications are very thin and short, designed specifically for subcutaneous (under the skin) use rather than deep muscle injections
Any menstrual changes are an indirect result of changes to weight or metabolic health
Fun Fact: Some athletes directly inject IGF-1 LR3 or IGF-1 DES for localized growth, bypassing the HGH-liver step
That means there is no safety data for that population
Utilize the Compounded Semaglutide Dosage Chart for Accurate Dosing To effectively utilize compounded semaglutide, please take a look at the dosage chart below: Week 1: 0.25 mg (10 units for insulin syringe) Week 2: 0.25 mg (10 units for insulin syringe) Week 3: 0.25 mg (10 units for insulin syringe) Week 4: 0.25 mg (10 units for insulin syringe) Week 5: 0.5 mg (20 units for insulin syringe) Week 6: 0.5 mg (20 units for insulin syringe) Week 7: 1.0 mg (40 units for insulin syringe) Week 8: 1.5 mg (60 units for insulin syringe) Week 9: 2.0 mg (80 units for insulin syringe) Week 10: 2.4 mg (96 units for insulin syringe) Start with a dose of 0.25 mg once weekly for the first four weeks
Putting myself in Pfizers shoes, the real kicker, beyond the potential for a better product profile, is how the potency and dosing of Metseras molecules lower API requirements and impact COGs